Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis

Abroad (travel likely)RecruitingPHASE2

Conditions

Hepatocellular Carcinoma · Cirrhosis, Liver

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

UT Health San Antonio, San Antonio, Texas, United States
Contact: Study coordinator (Sukeshi Arora, MD) · aroras@uthscsa.edu · 210-450-2872

Study leads

Sukeshi Arora, MD
Principal Investigator
The University of Texas Health Science Center at San Antonio

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.

Hepatocellular Carcinoma · Liver Cancer · Cirrhosis

Abroad (travel likely)Recruiting

Bondy, France

Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma · Stage III Hepatocellular Carcinoma AJCC v8 · Stage IIIA Hepatocellular Carcinoma AJCC v8

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Carcinoma, Hepatocellular · Hepatocellular Cancer · Hepatocellular Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · Los Angeles, United States

Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma · HCC

Abroad (travel likely)RecruitingPHASE2

Orange, United States